Sandor Victor
Insider CIK 1620368 · ARRY Chief Medical Officer. · MRUS Director · PRLD Director · ABCL Director · ADCT Director · KYMR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics Inc. | A Award deriv | 2026-07-01 | 2026-07-06 | 152,207 | — | $0 | 152,207 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2026-06-03 | 2026-06-03 | 12,600 | $3.08 | $38.8K | 140,686 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2026-06-01 | 2026-06-03 | 45,000 | — | $0 | 153,286 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,631 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 6,120 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 16,604 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 14,414 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,844 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 13,193 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 17,000 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-11-05 | 2025-11-07 | 121,285 | — | $0 | 121,285 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2025-06-13 | 2025-06-17 | 12,600 | $3.58 | $45.1K | 108,286 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-06-12 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2025-06-03 | 2025-06-05 | 40,000 | — | $0 | 120,886 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-05-22 | 2025-05-27 | 13,193 | — | $0 | 13,193 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2024-06-17 | 2024-06-18 | 6,995 | $2.89 | $20.2K | 80,886 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2024-06-13 | 2024-06-14 | 40,000 | — | $0 | 87,881 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 8,844 | — | $0 | 8,844 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-06-08 | 2023-06-12 | 14,414 | — | $0 | 14,414 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-11-03 | 2022-11-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 34,300 | — | $0 | 34,300 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-05-31 | 2022-06-02 | 16,604 | — | $0 | 16,604 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-01-03 | 2022-01-05 | 11,206 | — | $0 | 11,206 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-10-13 | 2021-10-14 | 8,022 | — | $0 | 8,022 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-06-18 | 2021-06-22 | 23,344 | — | $0 | 23,344 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-02 | 6,120 | — | $0 | 6,120 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2020-09-24 | 2020-09-28 | 3,458 | — | $0 | 3,458 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2020-06-30 | 2020-07-02 | 8,631 | — | $0 | 8,631 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 187,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 270,828 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 289,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 289,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 87,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 209,543 | $48.00 | $10.06M | 114,821 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 114,821 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-06-04 | 2019-06-06 | 100,000 | — | $0 | 87,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-06-04 | 2019-06-06 | 100,000 | $28.51 | $2.85M | 209,543 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-06-04 | 2019-06-06 | 100,000 | $7.30 | $730.0K | 309,543 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-06-03 | 2019-06-03 | 36,134 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-06-03 | 2019-06-03 | 36,134 | $3.65 | $131.9K | 245,677 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-06-03 | 2019-06-03 | 36,134 | $27.58 | $996.6K | 209,543 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-05-30 | 2019-06-03 | 15,728 | — | $0 | 36,134 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-05-30 | 2019-06-03 | 15,728 | $27.50 | $432.5K | 209,543 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-05-30 | 2019-06-03 | 15,728 | $3.65 | $57.4K | 225,271 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-05-28 | 2019-05-28 | 46,766 | — | $0 | 51,862 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-05-28 | 2019-05-28 | 74,915 | $27.00 | $2.02M | 209,543 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-05-28 | 2019-05-28 | 46,766 | $3.65 | $170.7K | 284,458 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-05-23 | 2019-05-28 | 40,634 | — | $0 | 98,628 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-05-23 | 2019-05-28 | 40,634 | $26.50 | $1.08M | 237,692 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-05-23 | 2019-05-28 | 40,634 | $3.65 | $148.3K | 278,326 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-05-21 | 2019-05-23 | 12,600 | — | $0 | 139,262 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-05-21 | 2019-05-23 | 12,600 | $26.50 | $333.9K | 237,692 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-05-21 | 2019-05-23 | 12,600 | $3.65 | $46.0K | 250,292 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 7,813 | — | $0 | 7,813 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 7,813 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-04-01 | 2019-04-03 | 15,626 | — | $0 | 244,624 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2019-04-01 | 2019-04-03 | 6,932 | $24.60 | $170.5K | 237,692 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-12-27 | 2019-01-02 | 6,268 | $14.05 | $88.1K | 228,998 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 11,284 | — | $0 | 22,570 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 12,062 | — | $0 | 36,188 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-12-16 | 2018-12-18 | 10,378 | $15.97 | $165.7K | 235,266 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-16 | 2018-12-18 | 23,346 | — | $0 | 245,644 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 289,500 | — | $0 | 289,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 48,250 | — | $0 | 48,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-03 | 2018-12-06 | 127,397 | — | $0 | 151,862 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-03 | 2018-12-06 | 127,397 | $3.65 | $465.0K | 337,483 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-12-03 | 2018-12-06 | 115,185 | $16.21 | $1.87M | 222,298 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-09-04 | 2018-09-05 | 9,687 | $15.38 | $149.0K | 210,086 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-27 | 2018-06-29 | 17,440 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-06-27 | 2018-06-29 | 7,753 | $18.50 | $143.4K | 219,773 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-27 | 2018-06-29 | 17,440 | — | $0 | 227,526 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-19 | 2018-06-21 | 77,576 | — | $0 | 279,259 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-19 | 2018-06-21 | 77,576 | $3.65 | $283.2K | 287,662 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-06-19 | 2018-06-21 | 77,576 | $18.76 | $1.46M | 210,086 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-13 | 2018-06-15 | 22,424 | — | $0 | 356,835 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-06-13 | 2018-06-15 | 22,424 | $18.75 | $420.4K | 210,086 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-13 | 2018-06-15 | 22,424 | $3.65 | $81.8K | 232,510 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-04-03 | 2018-04-03 | 8,689 | $15.35 | $133.4K | 210,086 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-04-01 | 2018-04-03 | 7,812 | — | $0 | 15,626 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-04-01 | 2018-04-03 | 6,936 | $16.32 | $113.2K | 218,775 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-04-01 | 2018-04-03 | 7,812 | — | $0 | 225,711 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-03-09 | 2018-03-09 | 182,191 | — | $0 | 379,259 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-03-09 | 2018-03-09 | 111,518 | $17.72 | $1.98M | 217,899 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-03-09 | 2018-03-09 | 182,191 | $3.65 | $665.0K | 373,915 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-03-09 | 2018-03-09 | 44,498 | $17.70 | $787.6K | 329,417 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 48,250 | — | $0 | 48,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-16 | 2017-12-19 | 11,284 | — | $0 | 33,854 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 289,500 | — | $0 | 289,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-16 | 2017-12-19 | 11,284 | $8.79 | $99.2K | 197,034 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-12-16 | 2017-12-19 | 5,310 | $10.92 | $58.0K | 191,724 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-04-01 | 2017-04-04 | 7,812 | — | $0 | 23,438 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-04 | 5,022 | $8.94 | $44.9K | 172,406 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-04-01 | 2017-04-04 | 7,812 | — | $0 | 177,428 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-06 | 7,303 | $8.94 | $65.3K | 170,125 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 270,828 | — | $0 | 270,828 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 45,138 | — | $0 | 45,138 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2016-09-22 | 2016-09-23 | 95,890 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2016-09-22 | 2016-09-23 | 95,890 | $3.69 | $353.8K | 200,733 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-09-22 | 2016-09-23 | 31,117 | $3.69 | $114.8K | 169,616 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 187,500 | — | $0 | 187,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 31,250 | — | $0 | 31,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-04-01 | 2016-04-05 | 2,651 | $3.00 | $8.0K | 104,843 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-09-22 | 2015-09-24 | 95,891 | — | $0 | 95,891 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-09-22 | 2015-09-24 | 31,165 | $5.18 | $161.4K | 107,494 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-09-22 | 2015-09-24 | 95,891 | $5.18 | $496.7K | 138,659 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-04-01 | 2015-04-03 | 187,500 | — | $0 | 187,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2015-04-01 | 2015-04-03 | 31,250 | — | $0 | 42,768 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-04 | 17,440 | — | $0 | 17,440 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-03-01 | 2015-03-04 | 17,440 | $7.96 | $138.8K | 17,440 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-03-01 | 2015-03-04 | 5,805 | $7.96 | $46.2K | 11,635 | SEC↗ |